Literature DB >> 7609778

Biphasic effects of sigma ligands on the neuronal response to N-methyl-D-aspartate.

R Bergeron1, C de Montigny, G Debonnel.   

Abstract

Previous studies from our laboratory have demonstrated that low doses of selective sigma (sigma) ligands potentiate the neuronal response to N-methyl-D-aspartate (NMDA) in the CA3 region of the rat dorsal hippocampus. Sertraline and clorgyline, two antidepressant drugs with a high affinity for receptors, also potentiate, at low doses, the NMDA response; however, when administered at higher sigma doses, the degree of potentiation induced by these two ligands progressively decreases (Bergeron et al. 1993). In the present experiments, the selective sigma ligands DTG, (+)pentazocine, BD-737, JO-1784 and L-687,384 were studied to determine if they would also generate bell-shaped dose-response curves. These ligands were administered intravenously at doses ranging from 1 micrograms/kg to 1 mg/kg or applied by microiontophoresis. They potentiated selectively, with bell-shaped dose-response curves, the NMDA-induced activation of pyramidal neurons in the CA3 region of the rat dorsal hippocampus. The potentiation of the NMDA response following the intravenous administration of a low dose of a sigma ligand persisted for at least 60 min, after which point in time a second injection of the same dose induced the same degree of potentiation. Moreover, a sustained potentiation was obtained during prolonged microiontophoretic applications of a sigma ligand. These two latter series of observations suggest that the lack of effect of the high doses of sigma ligands is not related to a rapid desensitisation of sigma receptors.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7609778     DOI: 10.1007/BF00233244

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  44 in total

Review 1.  Sigma receptors: biology and function.

Authors:  J M Walker; W D Bowen; F O Walker; R R Matsumoto; B De Costa; K C Rice
Journal:  Pharmacol Rev       Date:  1990-12       Impact factor: 25.468

2.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

3.  Comparison of the effects of the novel antipsychotic agent remoxipride on dopamine and noradrenaline turnover in the rat brain.

Authors:  O Magnusson; C J Fowler
Journal:  Pharmacol Toxicol       Date:  1989-10

Review 4.  Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity.

Authors:  C W Cotman; D T Monaghan; A H Ganong
Journal:  Annu Rev Neurosci       Date:  1988       Impact factor: 12.449

5.  Evidence for an anti-amnesic effect of JO 1784 in the rat: a potent and selective ligand for the sigma receptor.

Authors:  B Earley; M Burke; B E Leonard; C J Gouret; J L Junien
Journal:  Brain Res       Date:  1991-04-19       Impact factor: 3.252

6.  Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.

Authors:  B L Largent; A L Gundlach; S H Snyder
Journal:  J Pharmacol Exp Ther       Date:  1986-08       Impact factor: 4.030

7.  N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors.

Authors:  F P Monnet; G Debonnel; J L Junien; C De Montigny
Journal:  Eur J Pharmacol       Date:  1990-04-25       Impact factor: 4.432

8.  JO 1784, a potent and selective ligand for rat and mouse brain sigma-sites.

Authors:  F J Roman; X Pascaud; B Martin; D Vauché; J L Junien
Journal:  J Pharm Pharmacol       Date:  1990-06       Impact factor: 3.765

9.  Sigma and opioid receptors in human brain tumors.

Authors:  G E Thomas; M Szücs; J Y Mamone; W T Bem; M D Rush; F E Johnson; C J Coscia
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

10.  Behavioral evidence for a modulating role of sigma ligands in memory processes. II. Reversion of carbon monoxide-induced amnesia.

Authors:  T Maurice; M Hiramatsu; T Kameyama; T Hasegawa; T Nabeshima
Journal:  Brain Res       Date:  1994-05-30       Impact factor: 3.252

View more
  12 in total

1.  Pregnancy reduces brain sigma receptor function.

Authors:  R Bergeron; C de Montigny; G Debonnel
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

Review 2.  Sigma receptors: potential targets for a new class of antidepressant drug.

Authors:  James A Fishback; Matthew J Robson; Yan-Tong Xu; Rae R Matsumoto
Journal:  Pharmacol Ther       Date:  2010-05-11       Impact factor: 12.310

3.  Electrophysiological evidence for the implication of cholecystokinin in the modulation of the N-methyl-D-aspartate response by sigma ligands in the rat CA3 dorsal hippocampus.

Authors:  B Gronier; G Debonnel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-03       Impact factor: 3.000

4.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

5.  Sigma-1 and N-Methyl-d-Aspartate Receptors: A Partnership with Beneficial Outcomes.

Authors:  Mohan Pabba; Etienne Sibille
Journal:  Mol Neuropsychiatry       Date:  2015-03-11

6.  Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.

Authors:  F P Monnet; B R de Costa; W D Bowen
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

7.  The attenuation of learning impairments induced after exposure to CO or trimethyltin in mice by sigma (sigma) receptor ligands involves both sigma1 and sigma2 sites.

Authors:  T Maurice; V L Phan; Y Noda; K Yamada; A Privat; T Nabeshima
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

8.  Effects of low and high doses of selective sigma ligands: further evidence suggesting the existence of different subtypes of sigma receptors.

Authors:  R Bergeron; G Debonnel
Journal:  Psychopharmacology (Berl)       Date:  1997-02       Impact factor: 4.530

9.  Modulation of serotonergic neurotransmission by short- and long-term treatments with sigma ligands.

Authors:  J E Bermack; G Debonnel
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

Review 10.  The sigma-1 receptor: roles in neuronal plasticity and disease.

Authors:  Saïd Kourrich; Tsung-Ping Su; Michiko Fujimoto; Antonello Bonci
Journal:  Trends Neurosci       Date:  2012-10-23       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.